Ferring Pharmaceuticals Inc. et al v. Eugia Pharma Specialties Ltd. et al
| Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. and Polypeptide Laboratories A/S |
| Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC |
| 1:2022cv00017 |
| January 4, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 13, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to March 14, 2022 - filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) |
SO ORDERED re #8 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to March 14, 2022 (Set/Reset Answer Deadlines: AuroMedics Pharma LLC answer due 3/14/2022; Aurobindo Pharma Ltd. answer due 3/14/2022; Eugia Pharma Specialties Ltd. answer due 3/14/2022). ORDERED by Judge Maryellen Noreika on 1/13/2022. (dlw)
|
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
| Filing 7 SUMMONS Returned Executed by Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S, Ferring B.V., Ferring International Center S.A.. AuroMedics Pharma LLC served on 1/5/2022, answer due 1/26/2022. (Bourke, Mary) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Polypeptide Laboratories Holding AB, Corporate Parent Polypeptide Group AG for Polypeptide Laboratories A/S; Corporate Parent Ferring Holding S.A. for Ferring B.V., Ferring International Center S.A.; Corporate Parent Ferring Holding Inc., Corporate Parent Ferring B.V. for Ferring Pharmaceuticals Inc. filed by Ferring B.V., Ferring International Center S.A., Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S. (Bourke, Mary) |
| Filing 5 Summons Issued with Magistrate Consent Notice attached as to AuroMedics Pharma LLC on 1/4/2022. (apk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)(SEE ATTACHED) (apk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/25/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 5/25/2024. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT filed against AuroMedics Pharma LLC, Aurobindo Pharma Ltd., Eugia Pharma Specialties Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3774264.) - filed by Ferring Pharmaceuticals Inc., Polypeptide Laboratories A/S, Ferring B.V., Ferring International Center S.A.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
